MedTrace Logo

Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia

NCT03876470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-04-17

No results posted yet for this study

Summary

The objective of this protocol is to conduct a comprehensive quantitative and qualitative assessment of the impact of our innovative collaborative telehealth HCV care model on patient treatment experiences and quality of life.

Conditions

  • Hepatitis C

Interventions

OTHER

Hepatitis C treatment as chosen by provider

Participants' providers will determine the type of HCV treatment as appropriate.

Sponsors & Collaborators

Principal Investigators

  • Rebecca Dillingham, MD · University of Virginia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2020-11-30
Completion
2020-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03876470 on ClinicalTrials.gov